Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete in dry eye disease
NCT06188260Phase 2Completed
- Sponsor
- The Hong Kong Polytechnic University
- Start
- Jan 2024
- Primary completion
- Nov 2024
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye syndrome (DED), sponsored by The Hong Kong Polytechnic University. Started Jan 2024; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06188260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188260.